We aim to further improve quality and reliability through an integrated system that encompasses functions ranging from development to production and distribution.

Zeria’s spirit of manufacturing, “placing top priority on quality and properly producing even better products,” has been passed down since our founding.

In keeping with this spirit, Zeria has built an optimal production structure underpinned by the Saitama Plant, the Tsukuba Plant, IONA’s Fukushima Plant, Kenso-Seiyaku’s Tsukuba Plant, Tillotts Pharma’s Ziefen Plant, ZPD’s Esbjerg Plant and F.T. Pharma’s Cat Lai Plant. Through this framework, Zeria makes its utmost efforts to manufacture high quality and highly reliable products.

The Saitama Plant produces a variety of ethical pharmaceuticals and OTC drug products as the center of Zeria’s production facilities. The Tsukuba Plant, which produces a range of products classified as OTC drugs, designated quasi-drugs, health foods and drinks, features a fully automated manufacturing line encompassing all processes from the placement of empty containers to packaging.

Both plants have obtained certification for ISO 14001, the international standard for environmental management systems, and are undertaking environmentally conscious production activities. The distribution of pharmaceuticals requires a variety of response capabilities that include the distribution management ability to handle largemix small-quantity production, make immediate delivery and reduce inventory volumes. To respond to the specialized requirements of drug distribution, Zeria aims to reduce distribution costs and realize
fast and accurate delivery. These efforts are focused on our targets of achieving “365-day operation and shipment,” “shortening lead time,” “reducing wasteful costs” and “improving distribution quality.”